News
-
Submit podium presentation proposals by February 28, 2014 at http://www.rddonline.com/rdd/speaker_reg.php?id=10 Workshop proposals should be submitted to http://www.rddonline.com/rdd/workshop_reg.php?id=10&sid=6 by February 14. Read more . . .
-
Rexam has announced the decision to sell all three divisions of its Healthcare business: Pharmaceutical Devices, Prescription Retail Packaging and Closures & Containers. Montagu Private Equity has made an offer of $805 million for the… Read more . . .
-
Sanofi US consumer healthcare division Chattem has announced that Nasacort Allergy 24HR Nasal Spray is now available over the counter in the United States. The FDA approved the triamcinolone acetonide nasal spray as an OTC… Read more . . .
-
Bill Doub is Lead Chemist, R&D in the FDA’s Division of Pharmaceutical Analysis, which is part of the Office of Pharmaceutical Science in the Center for Drug Evaluation and Research (CDER). . . . Read… Read more . . .
-
Civitas Therapeutics has announced that former Sunovion CEO Mark Iwicki will succeed Glenn Batchelder as President and Chief Executive Officer. Iwicki was most recently CEO of Blend Therapeutics. According to Civitas, which is developing inhaled… Read more . . .
-
According to Avanir Pharmaceuticals, the company has submitted a 505(b)(2) New Drug Application (NDA) for its AVP-825 intranasal dry powder sumatriptan for the treatment of migraine to the FDA. Avanir acquired the North American license… Read more . . .
-
Romania has approved the 50 µg/500 µg dose version of Sandoz’s AirFluSal Forspiro salmeterol/fluticasone DPI for the treatment of asthma and COPD, triggering a €1.5 million milestone payment to Vectura. The inhaler has also been… Read more . . .
-
Copley Scientific has announced the launch of its BAC 2000 breath actuated controller and BRS 1100 breathing simulator for the testing of MDIs with spacers and valved holding chambers in accordance with draft US Pharmacopoeia… Read more . . .
-
Prosonix has announced that a Phase 2 clinical study of its PSX1002 glycopyrronium bromide MDI in 37 COPD patients demonstrated statistically significant improvement in lung function compared to placebo for a range of doses. PSX1002… Read more . . .
-
Evoke Pharma has published a Phase 2b study demonstrating superior efficacy of intranasal metoclopramide compared to oral metoclopramide for the management of diabetic gastroparesis symptoms. The study appears in an upcoming issue of Neurogastroenterology &… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland